Philip Morris International Inc. (PMI) Q2 2026 Financial Results: Detailed Investor Analysis
Ticker: PM
Exchange: New York Stock Exchange
Report Type: Quarterly Report (Form 10-Q)
Period Ended: June 30, 2026
Key Highlights from the Q2 2026 Report
- Net Earnings: PMI reported net earnings of \$5.57 billion for the first six months of 2026, compared to \$5.99 billion in the prior year period. For the second quarter (three months ended June 30, 2026), net earnings were \$2.99 billion, down from \$3.15 billion in Q2 2025.
- Net Earnings Attributable to PMI: For H1 2026, net earnings attributable to PMI were \$5.26 billion (down from \$5.73 billion in H1 2025). For Q2, this figure was \$2.82 billion (down from \$3.04 billion in Q2 2025).
- Earnings Per Share (EPS): Basic and diluted EPS for H1 2026 were \$3.36, compared to \$3.67 in H1 2025. For Q2, EPS was \$1.80 (inferred by dividing quarterly net income attributable to PMI by shares outstanding).
- Revenue and Gross Profit: Gross profit for H1 2026 rose to \$14.56 billion from \$13.14 billion a year earlier; for Q2, gross profit was \$6.87 billion (up from \$6.22 billion in Q2 2025).
- Operating Expenses: Marketing, administration, and research costs increased slightly to \$5.87 billion in H1 2026 (from \$5.64 billion), and were \$2.98 billion in Q2 2026 (flat year-over-year).
- Impairment Losses: The company recorded a \$511 million impairment related to the RBH equity investment in both H1 and Q2 2026. This is a new and potentially material item for investors.
- Equity Income: Equity investments and securities produced a net income of \$244 million in H1 2026, versus a net loss of \$115 million in H1 2025. For Q2, the figure was a gain of \$159 million versus a loss of \$376 million a year prior.
- Tax Expense: Income tax expense for H1 2026 was \$1.63 billion, up from \$1.31 billion in H1 2025; for Q2 2026, it was \$955 million (Q2 2025: \$652 million).
- Shares Outstanding: As of the report date, PMI had 1,513,439,000 shares of common stock outstanding.
Important Shareholder and Price-Sensitive Information
- Impairment Related to RBH Equity Investment: The \$511 million impairment related to the RBH investment is a significant non-cash charge and could be viewed negatively by the market. This may reflect challenges or reduced prospects for this investment, and investors should assess its impact on future earnings and asset value.
- Declining Net Earnings: Both net earnings and EPS declined year-over-year for both the six-month and three-month periods. This trend could weigh on the share price, especially if the market was expecting growth or at least flat performance.
- Margin Pressure: While gross profit increased, the rise in operating expenses and higher income tax expense compressed net margins. The company will likely face scrutiny on its cost control and tax planning.
- Equity Investment Performance Improvement: The swing from a loss to a gain in equity investments and securities is a positive, partially offsetting other negative trends.
- Security Listings: The company has a broad range of outstanding notes listed on the NYSE, indicating a significant debt profile that investors should consider in their risk assessment.
Additional Investor-Relevant Details
- PMI remains a Large Accelerated Filer and is not an emerging growth company, nor a shell company.
- All required reports and interactive data files have been filed timely, indicating compliance and no regulatory issues at present.
- The company’s common stock trading symbol is PM on the NYSE.
- PMI’s fiscal year ends on December 31st.
- The company has a diverse portfolio of long-term notes maturing from 2026 to 2044, reflecting a long-term debt structure and substantial ongoing financial obligations.
Potential Share Price Movers
- Impairment Charge: The \$511 million impairment on the RBH equity investment is a new and material negative that could pressure the share price.
- Year-over-Year Declines in Earnings and EPS: Investors and analysts may react negatively to the profit and EPS declines, unless there are mitigating factors discussed in management’s commentary (not included in the provided data).
- Higher Income Tax Expense: The increased tax bill may indicate reduced future net earnings unless offset by operating improvements.
- Positive Shift in Equity Investment Returns: This could provide some optimism, but may not be enough to offset the other negative trends.
Conclusion
PMI’s Q2 2026 financial report reveals a mixed picture: while gross profits and equity investment performance improved, the company faces headwinds from a significant impairment charge and declining net earnings. These developments are likely to be closely watched by investors and could impact the company’s share price in the near term. Investors should pay particular attention to management’s discussion of the RBH impairment and strategies for restoring earnings growth.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full SEC filing and consult with their financial advisor before making any investment decisions. The information provided is based on the company’s Form 10-Q for the period ended June 30, 2026, and may be subject to further updates or clarifications from the company.
